Published in Pharma Law Weekly, May 13th, 2008
"This study aims to identify predictors for successful marketing authorisation of potential orphan drugs in the EU. A comparison between randomly selected authorised and a matched sample of not-yet-authorised orphan drug designations has been performed. Determinants in the study included characteristics of the indication, of the product and of the sponsor. Data were collected from...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly